FOLLOWUS
1.Key Laboratory of Liver and Kidney Diseases, Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai (201203), China
2.Department of Integrated Chinese and Western Medicine,Hangzhou Xixi Hospital, Hangzhou (310023), China
3.National Engineering Center for Biochip at Shanghai, Shanghai (201203),China
4.Institute of Clinical Pharmacology, Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai (201203), China
5.Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai (201203), China
Dr. ZHAO Yu, E-mail: cathy150@139.com
纸质出版日期:2022-01-01,
网络出版日期:2020-09-11,
录用日期:2020-04-17
Scan for full text
Yi-shuang TANG, Jian-chun GUO, Lin XU, 等. 外周血多组学综合分析慢性乙型肝炎不同苔色患者的病理基础[J]. Chinese Journal of Integrative Medicine, 2022,28(1):28-35.
Yi-shuang TANG, Jian-chun GUO, Lin XU, et al. Pathological Change of Chronic Hepatitis B Patients with Different Tongue Coatings by Circular Multi-omics Integrated Analysis[J]. Chinese Journal of Integrative Medicine, 2022,28(1):28-35.
Yi-shuang TANG, Jian-chun GUO, Lin XU, 等. 外周血多组学综合分析慢性乙型肝炎不同苔色患者的病理基础[J]. Chinese Journal of Integrative Medicine, 2022,28(1):28-35. DOI: 10.1007/s11655-020-3275-4.
Yi-shuang TANG, Jian-chun GUO, Lin XU, et al. Pathological Change of Chronic Hepatitis B Patients with Different Tongue Coatings by Circular Multi-omics Integrated Analysis[J]. Chinese Journal of Integrative Medicine, 2022,28(1):28-35. DOI: 10.1007/s11655-020-3275-4.
目的:
2
中医药已被证实可有效防治慢性肝病
但中医理论的现代生物学基础尚缺乏阐释. 舌诊是中医的个性化诊疗的重要依据
本研究旨在比较慢性乙型肝炎 (CHB) 不同苔色患者的循环病理变化.
方法:
2
本研究将41例CHB白苔 (WTC) 及黄苔 (YTC) 患者纳入研究
并将14名正常舌象的健康志愿者作为对照. 通过转录组芯片检测受试者外周血白细胞mRNA表达
并随机选择9个mRNA进行芯片检测结果验证. 采用气相色谱-质谱法检测分析外周血代谢物谱变化. 采用IPA分析平台或在线代谢组学数据库进行生物信息分析
应用ClueGO构建生物网络.
结果:
2
与健康志愿者比较
在WTC和YTC患者中分别发现了945和716个差异基因. 通过对差异基因的功能富集分析发现
不论苔色表现如何
CHB患者的外周血中细胞死亡、细胞凋亡和坏死的相关生物功能明显增加 (Z评分≥2
P
<
0.05)
T淋巴细胞活化明显降低 (Z评分≤–2
P
<
0.05) . 与WTC患者相比
生物学分析预测提示YTC患者病毒复制更活跃
且循环中脂肪酸类
如油酸和月桂酸的含量和柠檬酸循环相关代谢产物的含量较高(
P
<
0.1). 基于差异基因和代谢物的综合分析表明
TRAF6介导的NF-κB活化过程可能是WTC和YTC患者之间生物学功能网络的最大差异.
结论:
2
本研究结果提示
慢性乙型肝炎黄苔患者较白胎患者具有更严重的炎症和脂肪酸代谢紊乱. 研究结果为中医舌诊理论的现代病理学诠释提供了参考依据.
Objective:
2
To compare the circular pathological changes of chronic hepatitis B (CHB) patients according to the tongue diagnosis.
Methods:
2
Totally 41 CHB patients with typical white tongue coating (WTC) or yellow tongue coating (YTC) were enrolled and 14 healthy volunteers with normal tongue manifestation served as controls. The mRNA expression of peripheral leukocytes was detected by GeneChips
and 9 genes were randomly selected for expression validation. Circular metabolites were detected by gas chromatographymass spectrometry. Biological information was analyzed based on ingenuity pathways analysis or metabolomics database and the integrated networks were constructed by ClueGO.
Results:
2
A total of 945 and 716 differentially expressed genes were found in patients with WTC and YTC relative to healthy volunteers respectively. The biological information analysis indicated that CHB patients had obviously increased functions in cell death
apoptosis and necrosis (Z-score ≥2
P
<
0.05) and decreased activation in T lymphocytes (Z-score ≤–2
P
<
0.05)
regardless of the tongue manifestation. Compared to patients with WTC
the YTC patients were predicted to be more active in functions related to virus replication (Z-score ≥2
P
<
0.05)
and the content of circular fatty acids
such as oleic acid (
P
=0.098) and lauric acid (
P
=0.035)
and citric acid cycle-related metabolites were higher in the YTC patients (
P
<
0.1). The integrated analysis based on differential genes and metabolites indicated that the most difference in the biological function network between the WTC and YTC patients was tumor necrosis factor receptor associated factor 6 mediated-nuclear factor kappa-B activation process.
Conclusions:
2
CHB patients with YTC had more severe inflammation and fatty acids metabolism aberrant than patients with WTC. The results facilitate the modern pathological annotation of Chinese medicine tongue diagnosis theory and provide a reference for the interpretation of pharmacological mechanisms of Chinese medicine treatment.
Chinese medicinechronic hepatitis Btongue diagnosismetabolomicstranscriptomic
Seto WK, Lo YR, Pawlotsky JM, Yuen MF. Chronic hepatitis B virus infection. Lancet 2018;392:2313-2324.
Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009;373:582-592.
GBD Mortality and Causes of Death Collaborators. Global,regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117-171.
Zhang L, Wang G, Hou W, Li P, Dulin A, Bonkovsky HL.Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review. Hepatology 2010;51:690-698.
Wang BE. Treatment of chronic liver diseases with traditional Chinese medicine. J Gastroenterol Hepatol 2000;15 (Suppl):E67–E70.
Tsai TY, Livneh H, Hung TH, Lin IH, Lu MC, Yeh CC.Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study.BMJ Open 2017;7:e014571.
Ye J, Cai X, Yang J, Sun X, Hu C, Xia J, et al. Bacillus as a potential diagnostic marker for yellow tongue coating. Sci Rep 2016;6:32496.
Sun ZM, Zhao J, Qian P, Wang YQ, Zhang WF, Guo CR, et al. Metabolic markers and microecological characteristics of tongue coating in patients with chronic gastritis. BMC Complement Altern Med 2013;13:227.
Zhao Y, Mao YF, Tang YS, Ni MZ, Liu QH, Wang Y, et al. Altered oral microbiota in chronic hepatitis B patients with different tongue coatings. World J Gastroenterol 2018;24:3448-3461.
Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B(2010 version). Chin J Hepatol (Chin) 2011;19:13-24.
Internal Medicine Hepatopathy Committee of Chinese Traditional Medicine Association. The standards of TCM differential syndromes of viral hepatitis. J Tradit Chin Med(Chin) 1992;5:39-40.
Zhao Y, Gou XJ, Dai JY, Peng JH, Feng Q, Sun SJ, et al.Differences in metabolites of different tongue coatings in patients with chronic hepatitis B. Evid Based Complement Alternat Med 2013;2013:204908.
Dai J, Sun S, Cao J, Zhao Y, Cao H, Zheng N, et al. Similar connotation in chronic hepatitis B and nonalcoholic fatty liver patients with dampness-heat syndrome. Evid Based Complement Alternat Med 2013;2013:793820.
Masson JJR, Billings HWW, Palmer CS. Metabolic reprogramming during hepatitis B disease progression offers novel diagnostic and therapeutic opportunities. Antivir Chem Chemother 2017;25:53-57.
Yang L, Yang X, Kong X, Cao Z, Zhang Y, Hu Y, et al.Covariation analysis of serumal and urinary metabolites suggests aberrant glycine and fatty acid metabolism in chronic hepatitis B. PLoS One 2016;11:e0156166.
Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH, Moon HB,et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARγ.Gastroenterology 2007;132:1955-1967.
Yang F, Yan S, He Y, Wang F, Song S, Guo Y, et al.Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver. J Hepatol 2008;48:12-19.
Luo G, Kim SJ, Khan M, Quan J, Till A, Subramani S, et al.Hepatitis B virus disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis. PLoS Pathogens 2013;9:e1003722.
Schoeman JC, Hou J, Harms AC, Vreeken RJ, Berger R, Hankemeier T, et al. Metabolic characterization of the natural progression of chronic hepatitis B. Genome Medicine 2016;8:1-13.
Sunami Y, Ringelhan M, Kokai E, Lu M, O'Connor T,Lorentzen A, et al. Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response. Hepatology 2016;63:1592-1607.
Namineni S, O'Connor T, Faure-Dupuy S, Johansen P, Riedl T,Liu K, et al. A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control. J Hepatology 2020;72:5.
Song H, Tan G, Yang Y, Cui A, Li H, Li T, et al. Hepatitis B virus-induced imbalance of inflammatory and antiviral signaling by differential phosphorylation of STAT1 in human monocytes. J Immunol 2019;202:2266-2275.
Zou ZQ, Zhang S, Lin Q, Qu RL, Li YF, Zhang FH, et al.Immune response- and viral control-related pathways in the progression of chronic hepatitis B. Microb Pathogen 2017;105:100-105.
Li JY, Cao HY, Sun L, Sun RF, Wu C, Bian YQ, et al.Therapeutic mechanism of Yin-Chen-Hao Decoction in hepatic diseases. World J Gastroenterol 2017;23:1125-1138.
Cai FF, Bian YQ, Wu R, Sun Y, Chen XL, Yang MD, et al. Yinchenhao Decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis. Biomed Pharmacother 2019;114:108863.
He F, Sun K, Peng J. Study on the functions of peripheral dendritic cells in chronic hepatitis B virus infection patients of Gan-depression Pi-deficiency syndrome and Gan-Dan dampness-heat syndrome under different immune states.Chin J Integr Trad West Med (Chin) 2011;31:1491-1495.
Zhao L, Wang L, Yan Y, Quan Z, Li Y, Ding Y. Correlation of chronic hepatitis B of dampness-heat resistance syndrome and Liver qi stagnation and Spleen deficiency syndrome with experimental index such as dendritic cell surface molecules and HBV-DNA viral load. Shanxi Med J (Chin) 2016;45:2222-2225.
van der Molen RG, Sprengers D, Binda RS, de Jong EC,Niesters HGM, Kusters JG, et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004;40:738-746.
Sun HH, Zhou DF, Zhou JY. The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturation. J Med Virol 2016;88:13-20.
Pearce EJ, Everts B. Dendritic cell metabolism. Nature Rev Immunol 2014;15:18-29.
Everts B, Amiel E, Huang SCC, Smith AM, Chang CH, Lam WY, et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKε supports the anabolic demands of dendritic cell activation. Nat Immunol 2014;15:323-332.
Rehman A, Hemmert KC, Ochi A, Jamal M, Henning JR,Barilla R, et al. Role of fatty-acid synthesis in dendritic cell generation and function. J Immunol 2013;190:4640-4649.
0
浏览量
2
Downloads
0
CSCD
关联资源
相关文章
相关作者
相关机构